Previously marketed by Roche as Zenapax to prevent acute rejection in kidney transplants patients, it was discontinued in this indication in 2009 due to lack of demand.

Interleukin-18 (IL-18) is a potent pro-inflammatory cytokine involved in host defense against infections and regulates the innate and acquired immune response. IL-18 is produced by both hematopoietic ...

The international experience of small bowel transplantation since 1985 has been compiled and analyzed through the International Intestinal Transplant Registry. [10] As of May 2001, the Registry ...

Ayres et al. Open-label, parallel group, 49 centers Moderate-to-severe asthma for over 2 years (≥ one ER visit and ≥ one oral corticosteroid per year) Positive skin prick to two clinically ...